Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-05-02 Sale | 2024-05-03 6:26 pm | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 3,152 | $18.91 | $59,604 | 363,679 (Indirect Direct) | View |
2023-05-02 Sale | 2023-05-03 6:25 pm | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 3,203 | $8.9049 | $28,522 | 366,831 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-08-12 Option Award | 2024-08-14 4:14 pm | N/A 2034-08-12 | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 503,125 | $0 | 503,125 (Direct) | View |
2024-05-01 Exercise | 2024-05-03 6:26 pm | N/A 2032-05-01 | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 10,417 | $0 | 363,679 (Direct) | View |
2023-08-17 Option Award | 2023-08-18 7:12 pm | N/A 2033-08-17 | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 600,000 | $0 | 600,000 (Direct) | View |
2023-05-01 Exercise | 2023-05-03 6:25 pm | N/A 2032-05-01 | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 10,416 | $0 | 366,831 (Direct) | View |
2022-08-08 Option Award | 2022-08-10 5:41 pm | N/A 2032-08-08 | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 550,000 | $0 | 550,000 (Direct) | View |
2022-05-01 Option Award | 2022-05-03 4:14 pm | N/A 2025-05-01 | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 31,250 | $0 | 31,250 (Direct) | View |
2021-08-17 Option Award | 2021-08-19 5:09 pm | N/A 2031-08-17 | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 400,000 | $0 | 400,000 (Direct) | View |
Ownership | 2021-03-25 9:38 pm | N/A N/A | Edgewise Therapeutics Inc. | EWTX | KOCH KEVIN President and CEO | 0 | $0 | 2,105,104 (Indirect) | View |
2020-05-21 Option Award | 2020-05-22 5:16 pm | N/A 2030-05-20 | MIRAGEN THERAPEUTICS INC. | MGEN | KOCH KEVIN Director | 24,000 | $0 | 24,000 (Direct) | View |